Letters: Cannabis is well studied, NORML says

Re “What are the benefits, risks of marijuana use? Experts are just finding out” (sacbee.com, Jan. 26): Claims that we just don’t know enough about cannabis fail to pass the smell test. A search on PubMed, the repository for all peer-reviewed published research, using the term “marijuana” yields more than 26,000 scientific papers referencing the plant or its constituents. This totality is far greater than that which exists for most conventional pharmaceuticals, such ibuprofen or acetaminophen. Further, for nearly two decades California has funded gold-standard, FDA-approved clinical trials assessing the safety and efficacy of cannabis in patient populations via the Center for Medicinal Cannabis Research. A review of its findings concludes: “Based on evidence currently available the Schedule I classification is not tenable; it is not accurate that cannabis has no medical value, or that information on safety is lacking.” It’s time we let facts, not fiction, guide the cannabis debate.

Paul Armentano, National Organization for the Reform of Marijuana Laws, Vallejo